Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.
about
Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathyClinical and Mechanistic Insights Into the Genetics of CardiomyopathyGenetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypesMolecular and physiological effects of overexpressing striated muscle beta-tropomyosin in the adult murine heartFounder mutations in hypertrophic cardiomyopathy patients in the NetherlandsA truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathyCardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update.Biophysical properties of human β-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy.Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers.Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.Counselling issues in familial hypertrophic cardiomyopathy.Genetic causes of human heart failure.β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutationsThe molecular genetic basis for hypertrophic cardiomyopathy.Mutation of the myosin converter domain alters cross-bridge elasticity.Molecular genetics and pathogenesis of hypertrophic cardiomyopathy.Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy.Molecular medicine in the 21st century.Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy.Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutationModifier genes for hypertrophic cardiomyopathyVIP gene deletion in mice causes cardiomyopathy associated with upregulation of heart failure genes.Molecular biology of heart disease.Genetics and clinical destiny: improving care in hypertrophic cardiomyopathyAlternative exon 9-encoded relay domains affect more than one communication pathway in the Drosophila myosin headHypertrophic cardiomyopathy: from gene defect to clinical disease.Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure.Unequal allelic expression of wild-type and mutated β-myosin in familial hypertrophic cardiomyopathy.Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chainGenetic basis of hypertrophic cardiomyopathy.Abnormal skeletal muscle bioenergetics in familial hypertrophic cardiomyopathy.Cardiac arrest and hypertrophic cardiomyopathy. Role of the implantable defibrillator.Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.Contemporary treatment of hypertrophic cardiomyopathyEvolving molecular diagnostics for familial cardiomyopathies: at the heart of it allFunctional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcomeHypertrophic cardiomyopathy in 2013: Current speculations and future perspectives.Genetic anticipation in a special form of hypertrophic cardiomyopathy with sudden cardiac death in a family with 74 members across 5 generations.Genetic biomarkers in hypertrophic cardiomyopathy.
P2860
Q24316488-F8967A27-97E9-48B0-B4E3-75A905B60781Q28075470-9A8BEAB7-4523-46BA-B94C-FCC7B3A4DA73Q28248327-D3BB2326-9845-4B30-883A-20DE5D52A64CQ28271303-11799882-3E15-49EE-AF64-725F6F76BB8CQ28283579-E07DCEE5-BD23-4DCE-AC17-62DDE7DB3676Q28508653-AF182FE9-0DBE-48E8-A1D7-C371996305D9Q30371882-8C2E6604-772D-48C7-8D8B-FF61BA81DCBEQ30838224-AA55C7A6-213D-4A2D-A4D8-3ABF0217788BQ33158326-E0F68418-51D7-4051-BFBC-A23DA5617DCCQ33167938-EA13A868-61CC-4B6D-863B-D1CE135507AEQ33680307-051954F9-78EB-4DF1-B24B-3F2290329AA8Q33683773-C7AF7BB4-DF52-4050-B059-0764D28EA587Q33864019-DA4DDF3B-373E-4742-8182-62E220FA64B9Q33939892-FB5FF3FC-3AE3-4905-A4F3-8BD41D912262Q34019053-A2CEBC9B-B475-46C4-A985-EA4C6B5CF57AQ34021080-649CC8A3-2D9F-4773-9F56-794E746DC721Q34028344-97A83061-1541-4769-9348-0ECF0C824654Q34322422-AEC0B7C3-28E8-464B-B1C0-43D97A3AFFC2Q34474908-523666BC-2E42-431A-81AC-B899445ABCC9Q34627120-95F526CA-DBF7-4F0D-86DB-F0F637F9A4A3Q34627221-631E78CE-C04E-40ED-B4C4-BABB48070F3CQ34641881-E18767A3-7FDE-4ECF-945C-4813039F420CQ34734925-8471A4AD-A2CF-4056-AA99-75A2F2C7DE27Q34863040-B2020733-1D8E-439C-B282-E41959DEDDBFQ34999606-970129D5-3BC9-46F5-80AC-45A08DA9EB9EQ35059426-EC286BD4-B33E-40EA-B91C-B43E33BD2DA2Q35087752-480D80C4-DD9A-49D8-96A5-45686CA4FE67Q35369864-7D761BF9-44C0-4061-8CEC-79574E647711Q35587444-9ABA2E8D-1029-42AB-9001-711C3F3D8211Q35792948-F39CC244-C6A7-4B4E-9985-20F06CF14D0FQ36686074-F712E411-2FDB-40F7-ADE9-0E73F87A051EQ36847169-A278BC8A-6E91-4E8E-BE88-327AF2C097EAQ36888495-792A95DC-E830-4017-B0EA-65C4307E318BQ36903712-67453690-70BE-46B6-9DDD-8F1DB822D425Q37227838-7EBCC50B-7D88-440B-80B0-9AD7958A25CBQ37255253-26A6D31B-A019-4A77-8621-8C7E418EBA87Q37362212-045950BB-D25B-4815-B5A0-40D787CAF8D0Q37603719-1B47B3BF-BB32-42AF-808A-85CBA195ED36Q37725295-2D5ABB2A-79F1-4CA8-A6FC-4D4FB7DC1FA1Q38125765-493E1F47-867A-4277-B31E-737C61BFD8B4
P2860
Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Prognostic implications of nov ...... l hypertrophic cardiomyopathy.
@ast
Prognostic implications of nov ...... l hypertrophic cardiomyopathy.
@en
Prognostic implications of nov ...... l hypertrophic cardiomyopathy.
@nl
type
label
Prognostic implications of nov ...... l hypertrophic cardiomyopathy.
@ast
Prognostic implications of nov ...... l hypertrophic cardiomyopathy.
@en
Prognostic implications of nov ...... l hypertrophic cardiomyopathy.
@nl
prefLabel
Prognostic implications of nov ...... l hypertrophic cardiomyopathy.
@ast
Prognostic implications of nov ...... l hypertrophic cardiomyopathy.
@en
Prognostic implications of nov ...... l hypertrophic cardiomyopathy.
@nl
P2093
P2860
P356
P1476
Prognostic implications of nov ...... l hypertrophic cardiomyopathy.
@en
P2093
L Thierfelder
W J McKenna
P2860
P304
P356
10.1172/JCI116957
P407
P577
1994-01-01T00:00:00Z